12:00 AM
 | 
Nov 11, 2013
 |  BC Week In Review  |  Financial News  |  Proposed Offerings

BioTime proposes follow-on

BioTime Inc. (NYSE-M:BTX), Alameda, Calif.
Business: Gene/Cell therapy, Pulmonary, Diagnostic
Date announced: 10/28/13
Type: Follow-on
To be raised: Up to $15 million...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >